X0206 3 2022-03-24 0 0001880438 AN2 Therapeutics, Inc. ANTX 0001783165 Adjuvant Global Health Technology Fund, L.P. C/O ADJUVANT CAPITAL, L.P 501 FIFTH AVENUE, SUITE 1404 NEW YORK NY 10017 0 0 1 0 0001799812 Adjuvant Global Health Technology Fund DE, L.P. C/O ADJUVANT CAPITAL, L.P 501 FIFTH AVENUE, SUITE 1404 NEW YORK NY 10017 0 0 1 0 Series A Convertible Preferred Stock Common Stock 1651636 I By Adjuvant Global Health Technology Fund, L.P. Series A Convertible Preferred Stock Common Stock 312415 I By Adjuvant Global Health Technology Fund DE, L.P. Series B Convertible Preferred Stock Common Stock 392433 I By Adjuvant Global Health Technology Fund, L.P. Series B Convertible Preferred Stock Common Stock 74230 I By Adjuvant Global Health Technology Fund DE, L.P. Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date. Shares held directly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"). The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). Kabeer Aziz, a member of the Issuer's board of directors, is a Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities. Shares held directly by Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE") . The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is the AC MGMT. Kabeer Aziz, a member of the Issuer's board of directors, is a Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities. Exhibit 24 - Power of Attorney /s/ Kabeer Aziz, Secretary of Adjuvant Global Health Technology Fund, L.P. 2022-03-24 /s/ Kabeer Aziz, Secretary of Adjuvant Global Health Technology Fund DE, L.P. 2022-03-24